Lobular carcinoma in situ: Difference between revisions
No edit summary |
|||
| Line 16: | Line 16: | ||
{{Lobular carcinoma in situ}} | {{Lobular carcinoma in situ}} | ||
{{CMG}} | {{CMG}} {{AE}}{{Faizan}} | ||
==[[Lobular carcinoma in situ overview|Overview]]== | ==[[Lobular carcinoma in situ overview|Overview]]== | ||
Revision as of 12:59, 18 August 2015
For patient information, click here
| Lobular carcinoma in situ |
Template:Lobular carcinoma in situ
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Faizan Sheraz, M.D. [2]
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Lobular carcinoma in situ from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications & Prognosis
Diagnosis
Staging | History and Symptoms | Physical Examination | Laboratory Findings | Chest X Ray | CT | MRI | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Case Studies
Related Chapters
Template:Skin and subcutaneous tissue symptoms and signs Template:Nervous and musculoskeletal system symptoms and signs Template:Urinary system symptoms and signs Template:Cognition, perception, emotional state and behaviour symptoms and signs Template:Speech and voice symptoms and signs Template:General symptoms and signs